RESUMO
INTRODUCTION: Information about seasonal distribution of Neuromyelitis optica spectrum disorders (NMOSD) attacks, particularly in tropical countries, has rarely been described and the reported data are diverse. OBJECTIVE: To evaluate influence of seasonal variation in NMOSD relapses in an equatorial country. PATIENTS AND METHODS: Exploratory observational, retrospective ecological study in a cohort of patients with NMOSD followed from January 2008 to December 2019. Data of demographic, clinical information, characteristics of relapses and seasonal temporal variation were recorded. Also, the annual, monthly and intra-annual seasonal variation of relapses was quantified. A negative binomial regression was used to estimate the associations between the number of relapses and climatic and temporal variables. RESULTS: One hundred thirteen patients were included, most of them were female (89.38%), with a mean age at NMOSD diagnosis was 44.97 (±13.98) and the median of relapses per patient were 2 relapses (IQR 1-3). The patients presented 237 relapses, most of these in AQP4 seropositive patients (87.76%) and longitudinal extensive myelitis was the most frequent type of relapse (53.59%). According to the temporal variation, relapses were more common in the second rainy season (28.69%) during November and December. However, there weren't significant differences in the number of relapses between seasons and climatic variables in the multivariable model. CONCLUSION: The number of NMOSD relapses in this equatorial country cohort did not exhibit any significant associations with climatic variations, including changes in rainy or dry seasons.
TITLE: Recaídas del trastorno de espectro de la neuromielitis óptica e influencia estacional en una cohorte de un país ecuatorial.Introducción. La evidencia sobre la distribución estacional de las recaídas del trastorno del espectro de la neuromielitis óptica (NMOSD), especialmente en países tropicales, es limitada y diversa. Objetivo. Evaluar la influencia de las variaciones estacionales en las recaídas del NMOSD en un país localizado sobre la línea ecuatorial. Pacientes y métodos. Se llevó a cabo un estudio ecológico, con información retrospectiva de una cohorte de pacientes con NMOSD atendida entre enero de 2003 y diciembre de 2020 en Medellín, Colombia. Se recolectaron datos demográficos y clínicos de los pacientes, así como información sobre variables estacionales y climáticas. Se calculó la frecuencia de recaídas por estación, mes y año, y se realizó una regresión binomial negativa para evaluar la asociación entre el número de recaídas, y las variables estacionales y climáticas. Resultados. Se incluyó a 113 pacientes, de los cuales el 89,38% eran mujeres, con una edad media en el momento del diagnóstico de NMOSD de 44,97 (±13,98) años y una mediana de tres recaídas (rango intercuartílico: 1-2). Se registraron 237 recaídas, la mayoría en pacientes seropositivos para anticuerpos antiacuaporina 4 (87,76%) y con mielitis longitudinal extensa como la presentación clínica más común (53,59%). Las recaídas se presentaron con mayor frecuencia durante la segunda temporada lluviosa (28,69%; n = 68), y en los meses de noviembre y diciembre. Sin embargo, en la regresión binomial negativa no se observó una asociación significativa entre el número de recaídas y las variables climáticas y estacionales, los meses y los años. Conclusión. Las variables climáticas y los patrones estacionales no muestran una asociación significativa con cambios en el número de recaídas del NMOSD en pacientes residentes en un país localizado sobre la línea ecuatorial.
Assuntos
Neuromielite Óptica , Humanos , Feminino , Masculino , Neuromielite Óptica/epidemiologia , Estações do Ano , Estudos Retrospectivos , Doença Crônica , Projetos de PesquisaRESUMO
INTRODUCTION: Disability in neuromyelitis optica spectrum disorder (NMOSD) is common and can be severe. AIM: To determine factors associated with increased disability in NMOSD. PATIENTS AND METHODS: Observational, analytical, ambispective study in a cohort of patients with NMOSD between January 2015 and July 2021, using a secondary source to review variables and the expanded disability status scale (EDSS) after onset and a primary source, with a telephone survey for the final EDSS and missing data. Major disability was defined as occurring when the EDSS score was = 6. The analysis was performed by means of logistic regression with SPSS 25®. RESULTS: A total of 125 patients were analysed. The average age at onset was 41 (standard deviation: 14) years, with a female-to-male ratio of 8:1. Of the total sample, 87% (109) were positive for anti-aquaporin antibodies. Optic neuritis (44.8%) and transverse myelitis (39.2%) were the most frequent clinical manifestations at onset. Altogether 71.2% of patients received acute treatment at their first relapse. Mean chronic treatment initiation was 12 months (interquartile range: 3-60) and 44% had difficulties with immunosuppression compliance. Of the total number of patients, 80.8% had relapses and 44% had a final EDSS score = 6. The median baseline-to-final EDSS score was 1 (interquartile range: 0-3), often towards disability accumulation. An association was found between a relapsing course (odds ratio = 3.73; p = 0.011) and a high baseline EDSS (odds ratio = 1.54; p = 0.0001) with increased disability. In the multivariate analysis, with a higher baseline EDSS and a relapsing course disability was 1.6 and 5.3 times more likely to occur, respectively. CONCLUSIONS: Disease relapses and high EDSS after the first episode are predictors of disability in NMOSD.
TITLE: Predictores de discapacidad en una cohorte con espectro de neuromielitis óptica.Introducción. La discapacidad en el espectro de neuromielitis óptica (NMOSD) es frecuente y puede ser grave. Objetivo. Determinar factores asociados a mayor discapacidad en el NMOSD. Pacientes y métodos. Estudio observacional, analítico, ambispectivo, en una cohorte de pacientes con NMOSD entre enero de 2015 y julio de 2021, utilizando una fuente secundaria para la revisión de variables y la escala extendida de discapacidad (EDSS) después del inicio y una fuente primaria, con una encuesta telefónica para la EDSS final y los datos faltantes. Se definió la discapacidad mayor cuando la puntuación de la EDSS era = 6. El análisis se realizó por medio de regresión logística con SPSS 25®. Resultados. Se analizó a 125 pacientes. La edad promedio de inicio fue 41 (desviación estándar: 14) años, con una relación mujer:hombre de 8:1. El 87% (109) era positivo para anticuerpos antiacuaporinas. La neuritis óptica (44,8%) y la mielitis transversa (39,2%) fueron las manifestaciones clínicas más frecuentes en el inicio. El 71,2% de los pacientes recibió tratamiento agudo en la primera recaída. La mediana de inicio del tratamiento crónico fue de 12 meses (rango intercuartílico: 3-60) y el 44% tuvo dificultades en el cumplimiento de la inmunosupresión. El 80,8% presentó recaídas y el 44% tenía una puntuación en la EDSS final = 6. La mediana de EDSS basal-final fue de 1 (rango intercuartílico, 0-3), con frecuencia hacia la acumulación de discapacidad. Se encontró asociación entre el curso con recaídas (odds ratio = 3,73; p = 0,011) y la EDSS basal alta (odds ratio = 1,54; p = 0,001) con una mayor discapacidad. En el análisis multivariado, una mayor EDSS basal y un curso con recaídas presentaron una probabilidad de discapacidad 1,6 y 5,3 veces mayor, respectivamente. Conclusiones. Las recaídas de la enfermedad y la EDSS alta después del primer episodio son predictores de discapacidad en el NMOSD.
Assuntos
Pessoas com Deficiência , Neuromielite Óptica , Estudos de Coortes , Feminino , Humanos , Masculino , Neuromielite Óptica/epidemiologia , Recidiva , Fatores de RiscoRESUMO
OBJECTIVE: Primary outcome was to evaluate complete improvement at six months after acute treatment in NMOSD relapses. METHODS: Retrospective observational cohort study of patients with diagnosis of NMOSD admitted for acute attacks. We performed an explanatory analysis using the univariate, bivariate and multivariate logistic regression approach. We compared survival curves using the Kaplan Meier analysis and estimated the median time for the main outcome. RESULTS: In the univariate analysis, basal EDSS score, AQP4-IgG positivity, PLEX as a first-line treatment (IVMP + PLEX), less systemic complications related to acute treatment and total attack history were independently associated with complete improvement at six months. After adjusting for confounding variables and using multivariate analysis by Cox Regression, positive AQ4-IgG (HR 0.04, 95% CI: 0.02-0.66) and IVMP + PLEX (HR 5.1, 95% CI: 3.9-66.4), were kept as independent factors associated to time to complete improvement. Time from admission to PLEX initiation and complete improvement at six months had a median of seven days (95% CI: 5.2-8.8). In secondary effects, there were no statistical differences between the groups. CONCLUSIONS: PLEX + IVMP is the treatment of choice for NMOSD relapses and should be initiated as early as possible.
RESUMO
Psychological approaches to the study of armed conflict have focused on analyzing post-traumatic stress outcomes, and on evaluating the intensity of exposure to violent confrontation. Nevertheless, psychometrically valid tools required for measuring these traumatic experiences are scarce To validate the Extreme Experiences scale (EX2) for armed conflict contexts for its use in Colombia, and to provide a framework for validation in conflict contexts around the world This Cross-sectional aims to validate the scale with 187 participants, study of validate with 187 participants, comprising population with high exposure to conflict (former combatants and a set of armed conflict victims) and low conflict-exposed individuals (control group). Structures of two domains and 18 items were confirmed: Direct Extreme Experiences (dEX2) and Indirect Extreme Experiences (iEX2); these dimensions were also validated by expert judgment, producing 14-item version. Good levels of internal consistency were found, with a KR-20 of 0.80 for the 18-item version, and 0.77 for the 14-item. The scale differentiates between population with 'high exposure to conflict' from population with 'low exposure' (dnp > 0.5 and area under the ROC >0.90). The scale scores have significant correlation with some mental health constructs. The EX2 scale has good internal consistency, as well as structural validity with regard to exposed groups. This scale can be potentially validated for its use in countries with armed confrontation history. In future versions, the scale may include additional items in order to improve content validity.
Assuntos
Conflitos Armados/psicologia , Inquéritos e Questionários/normas , Adulto , Estudos de Casos e Controles , Colômbia , Estudos Transversais , Feminino , Humanos , Masculino , PsicometriaRESUMO
BACKGROUND: Infantile haemangiomas (IH) are soft swellings of the skin that occur in 3-10% of infants. When haemangiomas occur in high-risk areas or when complications develop, active intervention is necessary. OBJECTIVE: To update a Cochrane Review assessing the interventions for the management of IH in children. METHODS: We searched for randomized controlled trials in CENTRAL, MEDLINE, Embase, LILACS, AMED, PsycINFO, CINAHL and six trials registers up to February 2017. We included 28 trials (1728 participants) assessing 12 interventions. RESULTS: We downgraded evidence from high to moderate/low for issues related to risk of bias and imprecision. Oral propranolol (3 mg kg-1 daily) probably improves clinician-assessed clearance vs placebo [risk ratio (RR) 16·61, 95% confidence interval (CI) 4·22-65·34; moderate quality of evidence (QoE)]; we found no evidence of a difference in terms of serious adverse events (RR 1·05, 95% CI 0·33-3·39; low QoE). We found the chance of reduction of redness may be improved with topical timolol maleate (0·5% gel applied twice daily) when compared with placebo (RR 8·11, 95% CI 1·09-60·09; low QoE). We found no instances of bradycardia or hypotension for this comparison. CONCLUSIONS: Our key results indicate that oral propranolol and topical timolol maleate are more beneficial than placebo in terms of clearance or other measures of resolution, or both, without an increase in harm.
Assuntos
Antagonistas Adrenérgicos beta/administração & dosagem , Hemangioma/tratamento farmacológico , Propranolol/administração & dosagem , Neoplasias Cutâneas/tratamento farmacológico , Timolol/administração & dosagem , Administração Cutânea , Administração Oral , Antagonistas Adrenérgicos beta/efeitos adversos , Bradicardia/induzido quimicamente , Bradicardia/epidemiologia , Abordagem GRADE , Humanos , Hipotensão/induzido quimicamente , Hipotensão/epidemiologia , Placebos/administração & dosagem , Placebos/efeitos adversos , Propranolol/efeitos adversos , Ensaios Clínicos Controlados Aleatórios como Assunto , Timolol/efeitos adversosRESUMO
Sufficient epidemiologic evidence has established an etiologic link between bladder cancer risk and occupational exposure as a painter to organic solvents. Currently, it remains to be established whether gene-specific promoter methylation contributes to bladder cancer development, including by enhancing chromosome breakage or loss. We investigated the effect of chronic exposure to organic solvents and paints on DNA methylation profiles in the promoter regions of four genes (GSTP1, p16(INK4a), APC and CDH1) and micronucleus (MN) frequency in exfoliated urothelial cells from voided urine from Colombian male non-smoking car painters and age-matched unexposed individuals. The exposed group had a higher percentage of individuals with >2 MNs/2000 cells compared with the unexposed group (P=0.04). Gene-specific analysis showed a significantly higher percentage of individuals with methylated GSTP1, p16(INK4a) and APC in the exposed group. Poisson regression analysis indicated that exposed individuals with methylated GSTP1 and p16(INK4a) promoters were more than twofold more likely to have an increase in MN frequency as compared with the reference. Finally, among exposed individuals with GSTP1 and p16(INK4a) methylated promoters, those with a greater age had a higher RR of increased MN frequency compared with younger exposed individuals with methylated promoters. These results support the conclusion that gene-specific promoter methylation may increase MN frequency in a dependent or independent interaction with occupational exposure to organic solvents.
Assuntos
Metilação de DNA , Testes para Micronúcleos , Exposição Ocupacional , Pintura/toxicidade , Regiões Promotoras Genéticas , Solventes/toxicidade , Urotélio/efeitos dos fármacos , Humanos , Masculino , Urotélio/citologiaRESUMO
En la actualidad, la enfermedad invasora por Haemophilus influenzae es un evento poco común en niños, particularmente, luego de la introducción de una vacuna altamente efectiva contra este microorganismo. Se presentan los casos de dos lactantes menores, previamente sanos, a quienes se les aisló de sangre y líquido cefalorraquídeo H. influenzae, dentro del contexto clínico de una sepsis y meningitis bacteriana. En el paciente pediátrico no vacunado o con esquemas de vacunación incompletos contra H. influenzae tipo b, debe considerarse este agente dentro del diagnóstico diferencial etiológico de los casos de infección bacteriana invasora.
Today, invasive disease due to Haemophilus influenzae is an extremely rare event in children, especially after the introduction of highly effective conjugated vaccines against this microorganism. We report two cases of previously healthy infants with H. influenzae within the clinical context of sepsis and bacterial meningitis. In unvaccinated pediatric patients or patients with incomplete vaccination schedules against H. influenzae type b, this pathogen should be considered in the differential etiological diagnosis of invasive bacterial infection.
Na atualidad, a doença invasora por Haemophilus influenzae é um evento pouco comum em crianças, particularmente, após da introdução de uma vacina altamente efetiva contra este microrganismo. Se apresentam os casos de duas lactantes menores, previamente saudáveis, a quem se lhes isolou de sangre e líquido cefalorraquidiano H. influenzae, dentro do contexto clínico de uma sepse e meningite bacteriana. No paciente pediátrico não vacinado ou com esquemas de vacinação incompletos contra H. influenzae tipo b, deve considerar-se este agente dentro do diagnóstico diferencial etiológico dos casos de infecção bacteriana invasora.
Assuntos
Humanos , Recém-Nascido , Lactente , Haemophilus influenzae , Vacinas , Líquido Cefalorraquidiano , Esquemas de Imunização , Vacinação , Bacteriemia , Menores de Idade , Imunidade , MeningiteRESUMO
An activated carbon Carbochem--PS230 was modified by chemical and thermal treatment in flow of H(2) in order to evaluate the influence of the activated carbon chemical surface in the adsorption of the monohydroxylated phenols. The solid-solution interaction was determined by analyzing the adsorption isotherms at 298 K at pH 7, 9 and 11 during 48 h. The adsorption capacity of activated carbons increases when the pH solution decreases. The amount adsorbed increases in the reduced carbon at the maximum adsorption pH and decreases in the oxidized carbon. In the sample of granulated activated carbon, CAG, the monohydroxylated phenols adsorption capacity diminishes in the following order catechol >hydroquinone >resorcinol, at the three pH values. The experimental data are evaluated with Freundlich's and Langmuir's models. The immersion enthalpies are determined and increase with the retained amount, ranging between 21.5 and 45.7 J g(-1). In addition, the immersion enthalpies show more interaction with the reduced activated carbon that has lower total acidity contents.
Assuntos
Adsorção , Carvão Vegetal , Fenóis/isolamento & purificação , Termodinâmica , Catecóis , Concentração de Íons de Hidrogênio , Hidroquinonas , Resorcinóis , Soluções , Purificação da Água/métodosRESUMO
This paper reports on a case of a 34-year male patient diagnosed for splenic lymphoma of the marginal zone, a rare entity in our milieu. Features of the disease are described. Early diagnosis is a must for optimum treatment of such a pathology, whose onset can be giant splenomegalia. All possible causes are to be considered.
Assuntos
Linfoma de Zona Marginal Tipo Células B , Neoplasias Esplênicas , Adulto , Humanos , Linfoma de Zona Marginal Tipo Células B/complicações , Linfoma de Zona Marginal Tipo Células B/diagnóstico , Linfoma de Zona Marginal Tipo Células B/diagnóstico por imagem , Linfoma de Zona Marginal Tipo Células B/patologia , Linfoma de Zona Marginal Tipo Células B/cirurgia , Masculino , Baço/patologia , Esplenectomia , Neoplasias Esplênicas/complicações , Neoplasias Esplênicas/diagnóstico , Neoplasias Esplênicas/diagnóstico por imagem , Neoplasias Esplênicas/patologia , Neoplasias Esplênicas/cirurgia , Esplenomegalia/etiologia , Tomografia Computadorizada por Raios X , Resultado do TratamentoRESUMO
The case of 20-years female patient with the diagnosis of sarcoidosis associated to fibrolamellar carcinoma of the liver is presented. Clinical features, diagnosis and treatment of these entities are exposed. The criteria of several researchers about the relation between sarcoidosis and neoplasic diseases are stood out. Sarcoidosis associated to fibrolamellar hepatocarcinoma is very uncommon.
Assuntos
Carcinoma Hepatocelular/patologia , Hepatopatias/complicações , Neoplasias Hepáticas/patologia , Sarcoidose/complicações , Adulto , Carcinoma Hepatocelular/complicações , Feminino , Humanos , Neoplasias Hepáticas/complicaçõesRESUMO
Objetivo: describir el consumo del medicamento metilfenidato.ritalina®, en el valle del Aburrá del departamento de Antioquia en el periodo de febrero a julio de 2003, en cuanto a la variación del consumo, las caracteristícas sociodemográficas de los pacientes que la consumen, así como en función de las variables de salud, aseguramiento y de medicamentos acompañantes. Métodos: estudio descriptivo longitudinal retrospectivo que tomó como fuente de información 1.917 pacientes consumidores del medicamento reportados oficialmente en el Fondo Rotatorio de Estupefacientes (FRE), con un tamaño muestral de 100 historias clínicas, 93 de las cuales se captaron mediante un formulario que permitió recolectar las variables de interés. Resultados: el consumo mínimo mensual fue de 150 miligramos y el máximo ascendió a 900 miligramos por paciente, con promedios mensuales que van de 362,9 a 398,4 miligramos por paciente. La tendencia de este consumo promedio total es visiblemente ascendente, con estabilización en niveles altos en los dos últimos meses. El 96,8 por ciento de todos los diagnósticos correspondió al trastorno por déficit de atención con hiperactividad (TDAH). El Instituto Neurológico y el Hospital Mental de Antioquia fueron las instituciones que más distribuyeron el medicamento o las que más fórmulas prescribieron a pacientes de ambos sexos, con 81,7 por ciento. El 46,2 por ciento son tratados simultáneamente con medicamentos alternos a la ritalina®. Conclusiones: con este estudio se contribuye a ampliar los conocimientos sobre las enfermedades y la medicación respectiva, además de mejorar los procedimientos administrativos establecidos en las entidades públicas encargadas de controlar el medicamento, lo que acarrea beneficios a la subregión antioqueña en cuanto a la ilustración y comprensión del tema estudiado.
Assuntos
Anfetaminas , Estimulantes do Sistema Nervoso Central , MetilfenidatoRESUMO
Sulfadoxine/pyrimethamine (SP) is considered an alternative treatment for acute uncomplicated malaria caused by Plasmodium falciparum resistant to chloroquine. However, the appearance of resistance to this drug has been reported since its initial use in Colombia. Molecular analysis of the dihydrofolate reductase gene indicates a correlation between in vitro resistance to SP and the Asn-108 point mutation. Little is known about the association of this point mutation and in vivo resistance to SP. We used a mutation-specific polymerase chain reaction strategy to analyze the presence of the Asn-108 point mutation in 48 clinical samples with adequate clinical response (ACR), 2 early treatment failures (ETF), and 1 late treatment failure (LTF). The Asn-108 mutation was detected in 36 of the ACR samples and in all of the ETF and LTF samples. Eleven ACR samples amplified with the wild-type-specific primer and one amplified with the primer for the Thr-108 mutation described for resistance to cycloguanil. These results suggest that the Asn-108 marker may not be useful in predicting SP treatment failure.
Assuntos
Antimaláricos/uso terapêutico , Malária Falciparum/tratamento farmacológico , Plasmodium falciparum/genética , Mutação Puntual , Pirimetamina/uso terapêutico , Sulfadoxina/uso terapêutico , Tetra-Hidrofolato Desidrogenase/genética , Animais , Combinação de Medicamentos , Resistência a Medicamentos/genética , Eletroforese em Gel de Ágar , Amplificação de Genes , Marcadores Genéticos , Humanos , Malária Falciparum/parasitologia , Plasmodium falciparum/efeitos dos fármacos , Reação em Cadeia da PolimeraseRESUMO
In order to evaluate the presence of specific IgG antibodies to Borrelia burgdorferi in patients with clinical manifestations associated with Lyme borreliosis in Cali, Colombia, 20 serum samples from patients with dermatologic signs, one cerebrospinal fluid (CSF) sample from a patient with chronic neurologic and arthritic manifestations, and twelve serum samples from individuals without clinical signs associated with Lyme borreliosis were analyzed by IgG Western blot. The results were interpreted following the recommendations of the Centers for Diseases Control and Prevention (CDC) for IgG Western blots. Four samples fulfilled the CDC criteria: two serum specimens from patients with morphea (localized scleroderma), the CSF from the patient with neurologic and arthritic manifestations, and one of the controls. Interpretation of positive serology for Lyme disease in non-endemic countries must be cautious. However these results suggest that the putative "Lyme-like" disease may correlate with positivity on Western blots, thus raising the possibility that a spirochete genospecies distinct from B. burgdorferi sensu stricto, or a Borrelia species other than B. burgdorferi sensu lato is the causative agent. Future work will focus on a survey of the local tick and rodent population for evidence of spirochete species that could be incriminated as the etiologic agent.
Assuntos
Anticorpos Antibacterianos/sangue , Grupo Borrelia Burgdorferi/imunologia , Imunoglobulina G/sangue , Doença de Lyme/etiologia , Western Blotting , Colômbia , Humanos , Doença de Lyme/sangue , Doença de Lyme/imunologia , Esclerodermia Localizada/complicaçõesRESUMO
Although chloroquine (CQ) resistance was first reported in Colombia in 1961 and sulfadoxine-pyrimethamine (SP) resistance in 1981, the frequency of treatment failures to these drugs in Colombia is unclear. A modified World Health Organization 14-day in vivo drug efficacy test for uncomplicated Plasmodium falciparum malaria in areas with intense malaria transmission was adapted to reflect the clinical and epidemiologic features of a low-intensity malaria transmission area in the Pacific Coast Region of Colombia. Patients > or =1 year of age with a parasite density > or =1,000 asexual parasites per microliter were enrolled in this study. Forty-four percent (24 of 54) of the CQ-treated patients were therapeutic failures, including 7 early treatment failures (ETFs) and 17 late treatment failures (LTFs). Four (6%) of 67 SP-treated patients were therapeutic failures (2 ETFs and 2 LTFs). Therapeutic failure in the CQ-treated group was associated with an age <15 years old (P < 0.01), but was not associated with initial parasite density, the presence of CQ or sulfa-containing drugs in urine, or a history of malaria. The high level of therapeutic failures to CQ detected in this study underscores the need and importance of drug efficacy evaluation in the development of a rational national antimalarial drug policy. The relatively low level of therapeutic failures to SP compared with other South American countries raises further questions regarding factors that might have prevented the rapid development of in vivo resistance to this drug combination.
Assuntos
Antimaláricos/uso terapêutico , Cloroquina/uso terapêutico , Malária Falciparum/tratamento farmacológico , Plasmodium falciparum/efeitos dos fármacos , Pirimetamina/uso terapêutico , Sulfadoxina/uso terapêutico , Adolescente , Adulto , Animais , Antimaláricos/farmacologia , Criança , Pré-Escolar , Cloroquina/farmacologia , Colômbia , Transmissão de Doença Infecciosa , Combinação de Medicamentos , Resistência a Medicamentos , Feminino , Humanos , Lactente , Malária Falciparum/transmissão , Masculino , Pessoa de Meia-Idade , Plasmodium falciparum/isolamento & purificação , Pirimetamina/farmacologia , Sulfadoxina/farmacologia , Falha de TratamentoRESUMO
Several point mutations in the dihydrofolate reductase (DHFR) gene of Plasmodium falciparum have been correlated with in vitro anti-folate drug resistance of laboratory and field isolates. Furthermore, two different point mutations that generate amino acid substitutions at the same position of the enzyme have been observed in all the isolates studied to date. These point mutations change a serine (Ser-108) in the wild type to an asparagine (Asn-108 mutation) or to a threonine (Thr-108 mutation). Using the polymerase chain reaction (PCR), it is possible to identify isolates that present these mutations. We used a mutation-specific PCR to screen 71 samples from several geographic locations of Colombia for the Asn-108 mutation (pyrimethamine resistance). In this initial screening 53 of 71 yielded amplification product with the DHFR mutation-specific primers. We further analyzed the 18 samples that did not amplify using a mutation-specific nested PCR. Of those 18 samples, seven amplified with primers specific for the Thr-108 mutation (proguanil resistance), one with the wild type (Ser-108), and 10 did not amplify. Of these 10 samples, three were identified as P. falciparum using a species-specific diagnostic nested PCR base on sequences from the small ribosomal RNA subunit gene. Overall, 51.6% of the samples amplified for the Asn-108 mutation, 10.9% for the Thr-108 mutation, 35.9% with the wild type specific primer, and 4.8% did not amplify with any of the DHFR primers. We observed variability in the frequency of the mutation between the different geographic location. The frequency of the Asn-108 and Thr-108 mutations in the state of Narifio was 25% each, while in Valle del Cauca the frequencies were 59% and 11%, respectively. These results contrast with observations in Brazil in which the Asn-108 mutation was found in 90% of the blood samples screened.
Assuntos
DNA de Protozoário/química , Malária Falciparum/parasitologia , Plasmodium falciparum/genética , Mutação Puntual , Tetra-Hidrofolato Desidrogenase/genética , Adolescente , Adulto , Animais , Asparagina/química , Criança , Pré-Escolar , Colômbia , DNA de Protozoário/sangue , Feminino , Frequência do Gene , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Parasitemia/parasitologia , Plasmodium falciparum/enzimologia , Reação em Cadeia da Polimerase , Serina/química , Tetra-Hidrofolato Desidrogenase/química , Treonina/químicaRESUMO
Reproductive patterns of wild cotton-top tamarin (Saguinus oedipus) females located in La Reserva Forestal Protectora Serranía de Coraza-Montes de María in Colosó, Colombia, were examined using long-term behavioral observations and fecal steroid analysis. Using an enzyme immunoassay, we analyzed fecal samples for E1C and PdG. Comparisons of reproductive cycles of a reproductively active female and her daughters were made. An inhibition of ovarian cycles has been observed in daughters living in their families. However, daughters also exhibited normal ovarian cycling that subsequently resulted in pregnancy. Factors influencing the fertility are discussed as they relate to the reproductive strategies of wild cotton-top tamarin females.
Assuntos
Fertilidade/fisiologia , Ciclo Menstrual/fisiologia , Saguinus/fisiologia , Animais , Estrona/análogos & derivados , Estrona/análise , Fezes/química , Feminino , Masculino , Pregnanodiol/análogos & derivados , Pregnanodiol/análiseRESUMO
Se estableció una colonia del mosquito Aedes taeniorhynchus, eficiente vector del virus de la encefalitis equina venezolana, tipo epidemo-epizoótico, a partir de formas adultas, recolectados en regiones cercanas a Barranquilla, Atlántico (Colombia). Se estudiaron algunos aspectos de la biología de este insecto (ciclo de vida y logevidad), elaboración de tablas de vida e igualmente se maximizaron algunos parámetros físicos, ambientales y nutricionales que garantizan el mantenimiento y la continuidad de la especie en condiciones de laboratorio. Esta colonia fue establecida con el objeto de proporcionar la materia prima biológica para los explantes de tejidos embrionarios que se han venido utilizando para establecer líneas celulares de crecimiento continuo
Assuntos
Animais , Aedes , Linhagem Celular , Colômbia , Estágios do Ciclo de Vida , LongevidadeRESUMO
We present reliable field techniques for capturing, anesthetizing, and Iidentifying individual cotton-top tamarins (Saguinus oedipus oedipus). A new technique is presented for radio-tracking small bodied primates. A backpack-style harness was designed to carry a transmitter. This system appears effective in minimizing potential injury and does not appear to interfere with the normal behavior of the animal. © 1993 Wiley-Liss, Inc.